Mechanism of gastrointestinal effects: Semaglutide mimics the naturally occurring hormone GLP-1, which is released from the intestine after eating
Under various inflammatory circumstances (such as lipopolysaccharides and acetic acid), NAC controls the expression of inflammatory cytokines (mRNA) and their secretion (protein) both in vitro and in vivo
The risk of the primary outcome was 24% lower in all participants treated with semaglutide versus placebo (95% confidence interval: 34%, 12%)
Remarkable products
Nouwen A, Nefs G, Caramlau I, Connock M, Winkley K, Lloyd CE, et al
By marketing products with "GLP-1" in the name or description, they capture search traffic and consumer interest driven by the pharmaceutical success story